Xcel Brands (XELB) 10-Q 13 Aug 24 2024 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Aug. 12, 2024
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-37527
Entity Registrant Name	XCEL BRANDS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	76-0307819
Entity Address, Address Line One	550 Seventh Avenue, 11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	347
Local Phone Number	727-2474
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	XELB
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		23,507,126
Entity Central Index Key	0001083220
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 924	$ 2,998
Accounts receivable, net of allowances for credit losses of $30 and $75 at June 30, 2024 and December 31, 2023, respectively	3,055	3,454
Inventory	407	453
Prepaid expenses and other current assets	378	398
Total current assets	4,764	7,303
Non-current Assets:
Property and equipment, net	214	634
Operating lease right-of-use assets	4,099	4,453
Trademarks and other intangibles, net	36,532	41,520
Equity method investments	16,643	17,735
Other assets	920	15
Total non-current assets	58,408	64,357
Total Assets	63,172	71,660
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	2,353	2,236
Deferred revenue	989	889
Accrued income taxes payable	372	372
Current portion of operating lease obligations	1,354	1,258
Current portion of long-term debt	1,000	750
Current portion of contingent obligation		964
Total current liabilities	6,068	6,469
Long-Term Liabilities:
Deferred revenue	3,111	3,556
Long-term portion of operating lease obligations	5,964	4,021
Long-term debt, net, less current portion	3,524	3,971
Long-term portion of contingent obligation		5,432
Other long-term liabilities	430	40
Total long-term liabilities	13,029	17,020
Total Liabilities	19,097	23,489
Commitments and Contingencies
Stockholders' Equity:
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value, 50,000,000 shares authorized, and 23,492,117 and 19,795,053 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	23	20
Paid-in capital	105,946	103,861
Accumulated deficit	(59,948)	(53,849)
Total Xcel Brands, Inc. stockholders' equity	46,021	50,032
Noncontrolling interest	(1,946)	(1,861)
Total Stockholders' Equity	44,075	48,171
Total Liabilities and Stockholders' Equity	$ 63,172	$ 71,660

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, net of allowances	$ 30	$ 75
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	23,492,117	19,795,053
Common stock, shares outstanding (in shares)	23,492,117	19,795,053

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Net revenue	$ 2,954,000	$ 6,781,000	$ 5,138,000	$ 12,831,000
Cost of goods sold	38,000	3,800,000	38,000	6,493,000
Gross profit	2,916,000	2,981,000	5,100,000	6,338,000
Direct operating costs and expenses
Salaries, benefits and employment taxes	1,630,000	2,241,000	3,563,000	5,706,000
Other selling, general and administrative expenses	1,490,000	2,943,000	3,519,000	6,436,000
Total direct operating costs and expenses	3,120,000	5,184,000	7,082,000	12,142,000
Operating loss before other operating costs and expenses (income)	(204,000)	(2,203,000)	(1,982,000)	(5,804,000)
Other operating costs and expenses (income)
Depreciation and amortization	1,545,000	1,786,000	3,134,000	3,583,000
Asset impairment charges	1,188,000		3,483,000	100,000
Loss from equity method investments	557,000	515,000	1,090,000	1,030,000
Gain on divestiture of Lori Goldstein Brand	(3,801,000)		(3,801,000)
Gain on sale of limited partner ownership interest		(351,000)		(351,000)
Gain on settlement of lease liability		(445,000)		(445,000)
Operating income (loss)	307,000	(3,708,000)	(5,888,000)	(9,621,000)
Interest and finance expense (income), net
Interest and finance expense (income), net	146,000	(7,000)	296,000	18,000
Income (loss) before income taxes	161,000	(3,701,000)	(6,184,000)	(9,639,000)
Income tax provision (benefit)	0	0	0	0
Net income (loss)	161,000	(3,701,000)	(6,184,000)	(9,639,000)
Net loss attributable to noncontrolling interest	(34,000)	(233,000)	(85,000)	(528,000)
Net income (loss) attributable to Xcel Brands, Inc. stockholders	$ 195,000	$ (3,468,000)	$ (6,099,000)	$ (9,111,000)
Earnings (loss) per common share attributable to Xcel Brands, Inc. stockholders:
Basic earnings (loss) per share	$ 0.01	$ (0.18)	$ (0.28)	$ (0.46)
Diluted earnings (loss) per share	$ 0.01	$ (0.18)	$ (0.28)	$ (0.46)
Weighted average number of common shares outstanding:
Basic weighted average common shares outstanding	23,491,238	19,735,500	21,933,079	19,684,630
Diluted weighted average common shares outstanding	23,539,886	19,735,500	21,933,079	19,684,630
Net licensing revenue
Revenues
Net revenue	$ 2,826,000	$ 2,428,000	$ 5,010,000	$ 4,650,000
Net sales
Revenues
Net revenue	$ 128,000	$ 4,353,000	$ 128,000	$ 8,181,000

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Public Offering and Private Placement Common Stock	Public Offering and Private Placement Paid-in Capital	Public Offering and Private Placement	Common Stock Consultants	Common Stock Director	Common Stock	Paid-in Capital Consultants	Paid-in Capital	Accumulated Deficit	Noncontrolling Interest	Consultants	Total
Balances at Dec. 31, 2022						$ 20		$ 103,592	$ (32,797)	$ (676)		$ 70,139
Balances (in shares) at Dec. 31, 2022						19,624,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to stock options and restricted stock								51				51
Shares issued to consultant in connection with stock grant							$ 6				$ 6
Shares issued to consultant in connection with stock grant (in shares)				8,334
Net loss									(5,643)	(295)		(5,938)
Balances at Mar. 31, 2023						$ 20		103,649	(38,440)	(971)		64,258
Balances (in shares) at Mar. 31, 2023						19,633,194
Balances at Dec. 31, 2022						$ 20		103,592	(32,797)	(676)		70,139
Balances (in shares) at Dec. 31, 2022						19,624,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss												(9,639)
Balances at Jun. 30, 2023						$ 20		103,715	(41,908)	(1,204)		60,623
Balances (in shares) at Jun. 30, 2023						19,700,656
Balances at Mar. 31, 2023						$ 20		103,649	(38,440)	(971)		64,258
Balances (in shares) at Mar. 31, 2023						19,633,194
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to stock options and restricted stock								27				27
Shares issued to consultant in connection with stock grant							39				39
Shares issued to consultant in connection with stock grant (in shares)				58,334
Shares issued on exercises of stock options, net of shares surrendered for cashless exercises (in shares)						9,128
Net loss									(3,468)	(233)		(3,701)
Balances at Jun. 30, 2023						$ 20		103,715	(41,908)	(1,204)		$ 60,623
Balances (in shares) at Jun. 30, 2023						19,700,656
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares issued (in shares)												19,795,053
Balances at Dec. 31, 2023						$ 20		103,861	(53,849)	(1,861)		$ 48,171
Balances (in shares) at Dec. 31, 2023						19,795,053
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to stock options and restricted stock								36				36
Shares issued to consultant in connection with stock grant							$ 98				$ 98
Shares issued to consultant in connection with stock grant (in shares)				78,000
Shares issued in connection with public offering and private placement transactions, net of transaction costs	$ 3	$ 1,899	$ 1,902
Contra-revenue related to warrants held by licensee								10				10
Net loss									(6,294)	(51)		(6,345)
Balances at Mar. 31, 2024						$ 23		105,904	(60,143)	(1,912)		43,872
Balances (in shares) at Mar. 31, 2024						23,452,117
Balances at Dec. 31, 2023						$ 20		103,861	(53,849)	(1,861)		48,171
Balances (in shares) at Dec. 31, 2023						19,795,053
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in connection with public offering and private placement transactions, net of transaction costs												1,902
Net loss												(6,184)
Balances at Jun. 30, 2024						$ 23		105,946	(59,948)	(1,946)		44,075
Balances (in shares) at Jun. 30, 2024						23,492,117
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in connection with public offering and private placement transactions, net of transaction costs			$ 1,900
Common stock, shares issued (in shares)			3,579,064
Common stock, shares issued (in shares)	3,579,064
Balances at Mar. 31, 2024						$ 23		105,904	(60,143)	(1,912)		43,872
Balances (in shares) at Mar. 31, 2024						23,452,117
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to stock options and restricted stock								32				32
Contra-revenue related to warrants held by licensee								10				10
Shares issued in connection with restricted stock grants (in shares)					40,000
Net loss									195	(34)		161
Balances at Jun. 30, 2024						$ 23		$ 105,946	$ (59,948)	$ (1,946)		$ 44,075
Balances (in shares) at Jun. 30, 2024						23,492,117
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares issued (in shares)												23,492,117

Unaudited Condensed Consolida_5

Unaudited Condensed Consolidated Statements of Cash Flows $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Cash flows from operating activities
Net loss	$ 161	$ (6,184)	$ (9,639)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	1,545	3,134	3,583
Asset impairment charges	1,188	3,483	100
Amortization of deferred finance costs included in interest expense		54
Stock-based compensation and cost of licensee warrants		186	122
Provision for (recovery of) credit losses		(45)
Undistributed proportional share of net loss of equity method investees		1,090	1,030
Gain on divestiture of Lori Goldstein Brand	(3,801)	(3,801)
Gain on sale of limited partner ownership interest			(351)
Gain on settlement of lease liability			(445)
Changes in operating assets and liabilities:
Accounts receivable		444	(1,768)
Inventory		46	2,047
Prepaid expenses and other current and non-current assets		(146)	863
Deferred revenue		(345)	5,041
Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities		(555)	(1,637)
Lease-related assets and liabilities		(634)	(417)
Other long-term liabilities		390
Net cash used in operating activities		(2,883)	(1,471)
Cash flows from investing activities
Net proceeds from sale of assets			451
Purchase of property and equipment		(104)	(81)
Net cash (used in) provided by investing activities		(104)	370
Cash flows from financing activities
Proceeds from public offering and private placement transactions, net of transaction costs		1,902
Payment of long-term debt		(250)
Net cash provided by financing activities		1,652
Net decrease in cash, cash equivalents, and restricted cash		(1,335)	(1,101)
Cash, cash equivalents, and restricted cash at beginning of period		2,998	4,608
Cash, cash equivalents, and restricted cash at end of period	1,663	1,663	3,507
Reconciliation to amounts on consolidated balance sheets:
Cash and cash equivalents	924	924	3,507
Restricted cash (reported in other non-current assets)	739	739
Total cash, cash equivalents, and restricted cash	$ 1,663	1,663	3,507
Supplemental disclosure of non-cash activities:
Recognition of operating lease right-of-use asset		2,596
Recognition of operating lease obligation		2,596
Supplemental disclosure of cash flow information:
Cash paid during the period for interest		$ 234
Cash paid during the period for income taxes			$ 16

Nature of Operations, Backgroun

Nature of Operations, Background, and Basis of Presentation	6 Months Ended
	Jun. 30, 2024
Nature of Operations, Background, and Basis of Presentation [Abstract]
Nature of Operations, Background, and Basis of Presentation	1. Nature of Operations, Background, and Basis of Presentation The accompanying condensed consolidated balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 19, 2024. The Company is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Currently, the Company’s brand portfolio consists of the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands. ● The Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company. ● The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party. ● The Company holds a noncontrolling interest in the Isaac Mizrahi Brand through its 30% ownership interest in IM Topco, LLC; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting. ● The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and launched in May 2024. The Company’s brand portfolio also included the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”) as a wholly owned brand from April 1, 2021 through June 30, 2024; the Lori Goldstein Brand was divested on June 30, 2024 (see Note 3 for additional details). The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that launched in April 2024. The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. Prior to and for a portion of 2023, the Company also engaged in wholesale and direct-to-consumer sales of products under its brands. The Company’s former wholesale and direct-to-consumer operations were presented as "Net sales" and "Cost of goods sold" in the condensed consolidated statements of operations, separately from the Company’s licensing revenues. The only net sales and cost of goods sold recognized for the three and six months ended June 30, 2024 were related to the final sale of certain residual jewelry inventories; as of June 30, 2024, the Company has no remaining jewelry inventory. The Company’s remaining inventory as of June 30, 2024 all relates to the Longaberger Brand, and the Company plans to sell off this remaining inventory by December 31, 2024. Liquidity and Management’s Plans The Company incurred a net loss attributable to Company stockholders of approximately $6.1 million during the six months ended June 30, 2024 (which included non-cash expenses of approximately $7.7 million), and had an accumulated deficit of approximately $59.9 million as of June 30, 2024. Net cash used in operating activities was approximately $2.9 million for the six months ended June 30, 2024. The Company had working capital (current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in common stock) of approximately $1.1 million as of June 30, 2024. The Company’s unrestricted cash and cash equivalents were approximately $0.9 million as of June 30, 2024. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern. ​ During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in 2022. In addition, during the first six months of 2024, management took actions which further reduced direct operating expenses to a run rate of approximately $12.5 million per annum, and going forward beginning in the third quarter of 2024, will reduce operating expenses to a run rate of approximately $10 million per annum, due to the elimination of expenses related to the Lori Goldstein Brand and reduction of executive cash compensation. Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity. During the six months ended June 30, 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity. Additionally, the Company entered into a divestiture transaction which relieved the Company of its contractual obligations to make future cash payments of approximately $1.0 million, and also relieved the Company of a potential future contingent obligation to make future cash payments of up to $11.3 million. Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of June 30, 2024, have been alleviated. ​

Investments in Unconsolidated A

Investments in Unconsolidated Affiliates and Variable Interest Entities	6 Months Ended
	Jun. 30, 2024
Investments in Unconsolidated Affiliates and Variable Interest Entities [Abstract]
Investments in Unconsolidated Affiliates and Variable Interest Entities	2. Investments in Unconsolidated Affiliates and Variable Interest Entities Investment in IM Topco, LLC On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP. The Company accounts for its 30% interest in the ongoing operations of IM Topco as other operating costs and expenses under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows: (i) first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement); (ii) second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and (iii) thereafter, in proportion to the members’ respective percentage interests. Further, on April 12, 2024, the Company, WHP, and IM Topco entered into an amendment of the business venture agreement, such that on and after January 1, 2026, WHP shall receive 50% of the net cash flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional net cash flow equal to $1,000,000. Based on these distribution provisions, the Company recognized an equity method loss related to its investment in IM Topco of $0.52 million for each of the three-month periods ended June 30, 2024 and 2023, and $1.03 million for each of the six-month periods ended June 30, 2024 and 2023. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for all of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal Xcel’s share of amortization expense. ​ Summarized financial information for IM Topco for the three and six months ended June 30, 2024 and 2023 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the six months ended ​ ​ June 30, ​ June 30, ($ in thousands) ​ 2024 ​ 2023 ​ 2024 ​ 2023 Revenues ​ $ 2,711 ​ $ 3,573 ​ $ 5,463 ​ $ 6,919 Gross profit ​ ​ 2,711 ​ ​ 3,573 ​ ​ 5,463 ​ ​ 6,919 (Loss) income from continuing operations ​ ​ (374) ​ ​ 206 ​ ​ (771) ​ ​ 113 Net (loss) income ​ ​ (374) ​ ​ 206 ​ ​ (771) ​ ​ 113 ​ Refer to Note 11 and Note 12 for additional information regarding the Company’s ongoing relationship with IM Topco. ​ Investment in Orme Live, Inc. In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment was $0.09 million and $0.15 million as of June 30, 2024 and December 31, 2023, respectively, and is included within other assets in the Company’s condensed consolidated balance sheets. The Company accounts for its 30% interest in the operations of ORME as a component of other operating costs and expenses under the equity method of accounting. The Company’s proportional share of the operating results of ORME for the three and six months ended June 30, 2024 was a loss of approximately $0.04 million and $0.06 million, respectively. Longaberger Licensing, LLC Variable Interest Entity Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

Divestiture Transaction

Divestiture Transaction	6 Months Ended
	Jun. 30, 2024
Proceeds from Divestiture of Businesses and Interests in Affiliates [Abstract]
Divestiture Transaction	3. Divestiture Transaction On June 21, 2024, the Company (through its wholly owned subsidiary, Gold Licensing, LLC) entered into an asset purchase agreement with Lori Goldstein and Lori Goldstein, Ltd (together the “LG Parties”), pursuant to which the Company agreed to sell, and the LG Parties agreed to purchase, substantially all of the assets of the Lori Goldstein Brand, including the “LOGO by Lori Goldstein” trademark and other intellectual property rights relating thereto. Also in conjunction with this transaction, key license agreements related to the Lori Goldstein Brand were assigned to and assumed by the LG Parties. This divestiture transaction closed on June 30, 2024. ​ As consideration for the sale of these assets, the parties agreed to the following: ​ ● The LG Parties waived their rights with respect to certain contingent consideration amounts that had been previously earned by the LG Parties (under the terms of the April 1, 2021 purchase of the assets by Xcel), and terminated their rights to any future earn-out payments. ​ ● The Company retained the right to all royalties and fee income for net sales from licensees related to the Lori Goldstein Brand through the closing date. ​ ● The Company’s May 2, 2024 termination of the employment agreement and consulting agreement with the LG Parties was withdrawn and stayed until the closing date. The Company paid Ms. Goldstein and Lori Goldstein, Ltd a combined total of $25,000 as compensation for services rendered under the employment agreement and consulting agreement through June 30, 2024, and also reimbursed Ms. Goldstein for expenses incurred in the course of fulfilling her duties under the employment agreement through June 30, 2024. ​ ● The Company and the LG Parties entered into a mutual general release and waiver of outstanding legal disputes. ​ Thus, the total consideration received by the Company for this divestiture transaction was approximately $6.08 million, comprised of (i) the waiver of approximately $1.03 million of accrued earn-out payments earned by the LG Parties through June 30, 2024, plus (ii) the release of the remaining balance of approximately $5.05 million of contingent obligations recorded on the Company’s balance sheet. The remaining unamortized net book value of the Lori Goldstein intangible assets immediately prior to the sale was approximately $1.93 million, and the Company also incurred approximately $0.35 million of legal fees in connection with this transaction. As such, the Company recorded a net non-cash gain on the divestiture of the Lori Goldstein Brand of approximately $3.80 million for the three and six months ended June 30, 2024.

Trademarks and Other Intangible

Trademarks and Other Intangibles	6 Months Ended
	Jun. 30, 2024
Trademarks and Other Intangibles [Abstract]
Trademarks and Other Intangibles	4. Trademarks and Other Intangibles Trademarks and other intangibles, net consist of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Average June 30, 2024 ​ Amortization ​ Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived) 15 years ​ 58,580 ​ 22,100 ​ 36,480 Copyrights and other intellectual property 8 years ​ 429 ​ 377 ​ 52 Total ​ ​ ​ $ 59,009 ​ $ 22,477 ​ $ 36,532 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Average December 31, 2023 ​ Amortization Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived) 15 years ​ 68,880 ​ 27,431 ​ 41,449 Copyrights and other intellectual property 8 years ​ 429 ​ 358 ​ 71 Total ​ $ 69,309 ​ $ 27,789 ​ $ 41,520 ​ Amortization expense for intangible assets was approximately $1.52 million for the three-month period ended June 30, 2024 (the "current quarter") and approximately $1.54 million for the three-month period ended June 30, 2023 (the "prior year quarter"). ​ Amortization expense for intangible assets was approximately $3.06 million for the six-month period ended June 30, 2024 (the "current six months") and approximately $3.07 million for the six-month period ended June 30, 2023 (the "prior year six months"). ​ On June 30, 2024, the Company sold certain trademarks with a net book value of approximately $1.93 million (gross carrying amount of $10.30 million and accumulated amortization of approximately $8.37 million) related to the Lori Goldstein Brand (see Note 3 for additional details).

Significant Contracts and Conce

Significant Contracts and Concentrations	6 Months Ended
	Jun. 30, 2024
Significant Contracts and Concentrations [Abstract]
Significant Contracts and Concentrations	5. Significant Contracts and Concentrations Qurate Agreements Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue. Net licensing revenue from the Qurate Agreements totaled $1.77 million and $1.63 million for the current quarter and prior year quarter, respectively, representing approximately 60% and 24% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. Net licensing revenue from the Qurate Agreements totaled $3.01 million and $3.28 million for the current six months and prior year six months, respectively, representing approximately 59% and 26% of the Company’s total net revenue for the current six months and prior year six months, respectively. As of June 30, 2024 and December 31, 2023, the Company had receivables from Qurate of $0.77 million and $1.5 million, respectively, representing approximately 25% and 43% of the Company’s total net accounts receivable, respectively. ​ Due to the divestiture of the Lori Goldstein Brand on June 30, 2024 (see Note 3 for details), the Company’s total net revenue, as well as the relative proportional share of total net revenue and total accounts receivable attributable to the Qurate Agreements, will decrease in future periods; however, due to the Company’s other brands, management expects that Qurate will remain a significant licensee. ​ Halston Master License On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.0 million and $4.4 million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of June 30, 2024 and December 31, 2023, respectively. As of December 31, 2023, approximately $0.9 million of the contract liability balance was classified as a current liability and approximately $3.5 million was classified as a long-term liability. As of June 30, 2024, approximately $0.9 million of the contract liability balance was classified as a current liability and approximately $3.1 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 3.88 years. Net licensing revenue recognized from the Halston Master License was $0.65 million and $1.29 million for the current quarter and current six months, respectively, representing approximately 22% and 25% of the Company’s total net revenue for the current quarter and current six months, respectively.

Leases

Leases	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Leases	6. Leases The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases. Lease expense (net of sublease income of approximately $0.2 and $0.3 million for the current quarter and current six months, respectively) included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.2 million for the current quarter, approximately $0.4 million for the prior year quarter, approximately $0.4 million for the current six months, and approximately $0.8 million for the prior year six months. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter, and approximately $0.8 million in both the current six months and prior year six months. As of June 30, 2024, the Company’s real estate leases have a weighted-average remaining lease term of approximately 4.97 years, and the lease liabilities are measured using a weighted-average discount rate of 7.71%. 1333 Broadway Lease The Company has an operating lease for offices located at 1333 Broadway, 10th floor, New York, New York, which commenced on March 1, 2016 and expires on October 30, 2027. The average annual fixed rent over the term of this lease is approximately $1.3 million per year, and the lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property. On January 26, 2024, the Company (as sublessor) entered into an agreement for the sublease of the offices located at 1333 Broadway to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of the sublease is approximately $0.8 million per year. As a result of entering into the sublease, the Company recognized a non-cash impairment charge of approximately $1.9 million effective February 29, 2024 (which was determined to be the date of a fundamental change to the use of the 1333 Broadway premises) related to the right-of-use asset. Also in connection with entering into the sublease, the Company recognized a non-cash impairment charge of approximately $0.4 million during the first quarter of 2024 related to leasehold improvement assets at this location. During the current quarter, the Company revised its estimates of future cash flows related to the 1333 Broadway premises (primarily as a result of new information) and accordingly recognized additional impairment charges related to this lease of approximately $1.2 million. A portion of the impairment charges recorded in the current quarter were related to an understatement of the asset impairment charge reported for the first quarter of 2024; see Note 13 for additional information. As of June 30, 2024, the Company’s lease of 1333 Broadway has a remaining lease term of approximately 3.33 years. 550 Seventh Avenue Lease Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and expires in April 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year. Upon commencement of the lease during the current quarter, the Company recognized a right-of-use asset and corresponding lease liability As of June 30, 2024, the Company’s lease of 550 Seventh Avenue has a remaining minimum lease term of approximately 7.83 years. Future Lease Obligations As of June 30, 2024, the maturities of future lease obligations were as follows: ​ ​ ​ ​ ​ ​ ​ Amount Year (in thousands) 2024 (July 1 through December 31) ​ $ 776 2025 ​ ​ 1,926 2026 ​ 2,060 2027 ​ 1,841 2028 ​ 570 Thereafter ​ 2,004 Total lease payments ​ ​ 9,177 Less: Discount ​ ​ 1,859 Present value of lease liabilities ​ ​ 7,318 Current portion of lease liabilities ​ ​ 1,354 Non-current portion of lease liabilities ​ $ 5,964 ​

Debt

Debt	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Debt	7. Debt The Company’s net carrying amount of debt is comprised of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ December 31, ($ in thousands) 2024 2023 Term loan debt ​ $ 4,750 ​ $ 5,000 Unamortized deferred finance costs related to term loan debt ​ (226) ​ (279) Total ​ 4,524 ​ 4,721 Current portion of debt ​ 1,000 ​ 750 Long-term debt ​ $ 3,524 ​ $ 3,971 ​ On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.3 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method. ​ In connection with this term loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement. Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement. ​ The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty. ​ As of June 30, 2024, the aggregate remaining principal payments under the term loan were as follows: ​ ​ ​ ​ ​ ​ ​ Amount of ($ in thousands) Principal Year Ending December 31, Payment 2024 (July 1 through December 31) ​ $ 500 2025 ​ 1,000 2026 ​ ​ 1,000 2027 ​ ​ 1,000 2028 ​ 1,250 Total ​ $ 4,750 ​ Interest on the term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month. In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount. The fair value of this swap agreement was immaterial as of June 30, 2024 and December 31, 2023. ​ For the current quarter and current six months, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.14 million and $0.29 million, respectively, reflecting an effective interest rate of approximately 11.6%. The term loan agreement also contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity	8. Stockholders’ Equity Public Offering and Private Placement Transactions On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share. The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million. Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation, which amount was offset against the proceeds received. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125 . The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering. In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589 , 132,589 , and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642 . Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering. The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million. Equity Incentive Plans A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board. In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan. Stock-based Compensation The Company accounts for stock-based compensation by recognizing the fair value of such compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable. Total expense recognized for all forms of stock-based compensation was approximately $0.03 million and $0.06 million for the current quarter and prior year quarter, respectively. Total expense recognized for all forms of stock-based compensation in the current six months and prior year six months was approximately $0.17 million and $0.12 million, respectively. For all periods presented, substantially all of the expense related to directors and consultants, and was recorded within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Stock Options A summary of the Company’s stock options activity for the current six months is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​ ​ Average ​ Contractual ​ Aggregate ​ ​ Number of ​ Exercise ​ Life ​ Intrinsic ​ Options Price (in Years) Value Outstanding at January 1, 2024 5,148,540 ​ $ 2.03 4.26 ​ $ — Granted 100,000 ​ 0.85 ​ Exercised — ​ — ​ Expired/Forfeited (472,780) ​ 3.08 ​ Outstanding at June 30, 2024, and expected to vest 4,775,760 ​ $ 1.90 4.13 ​ $ — Exercisable at June 30, 2024 1,025,760 ​ $ 2.67 1.83 ​ $ — ​ On April 3, 2024, the Company granted options to purchase an aggregate of 100,000 shares of common stock to non-management directors. The exercise price of the options is $0.85 per share, and 50% of the options vest on each of April 3, 2025 and April 3, 2026. ​ Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.02 million, respectively. Compensation expense related to stock options for the current six months and the prior year six months was approximately $0.03 million and $0.05 million, respectively. Total unrecognized compensation expense related to unvested stock options at June 30, 2024 was approximately $0.08 million and is expected to be recognized over a weighted average period of approximately 1.28 years. A summary of the Company’s non-vested stock options activity for the current six months is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ Average ​ ​ Number of ​ Grant Date ​ Options Fair Value Balance at January 1, 2024 3,750,000 ​ $ 0.04 Granted 100,000 ​ 0.47 Vested (100,000) ​ ​ 0.90 Forfeited or Canceled — ​ — Balance at June 30, 2024 3,750,000 ​ $ 0.03 ​ ​ Stock Awards A summary of the Company’s restricted stock activity for the current six months is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ Number of ​ Average ​ ​ Restricted ​ Grant Date ​ Shares Fair Value Outstanding at January 1, 2024 333,333 ​ $ 3.69 Granted 118,000 ​ 1.11 Vested (78,000) ​ 1.25 Expired/Forfeited — ​ — Outstanding at June 30, 2024 373,333 ​ $ 3.39 ​ On January 12, 2024, the Company issued 78,000 shares of common stock to a consultant, which vested immediately. On April 3, 2024, the Company issued an aggregate of 40,000 shares of common stock to non-management directors, of which 50% shall vest on April 3, 2025, and 50% shall vest on April 3, 2026. Compensation expense related to stock awards was approximately $0.02 million for the current quarter and approximately $0.05 million for the prior year quarter. Compensation expense related to stock awards was approximately $0.13 million for the current six months and approximately $0.08 million for the prior year six months. Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2024 was approximately $0.06 million and is expected to be recognized over a weighted average period of approximately 1.27 years. Restricted Stock Units There were no restricted stock units outstanding as of June 30, 2024 and December 31, 2023, and no restricted stock units have been issued since the inception of the 2021 Plan. Shares Available Under the Company’s Equity Incentive Plans At June 30, 2024, there were 2,945,291 shares of common stock available for future award grants under the 2021 Plan. Shares Reserved for Issuance As of June 30, 2024, there were 7,837,116 shares of common stock reserved for issuance under the Company’s Equity Incentive Plans, including 4,357,825 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 534,000 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 2,945,291 shares available for issuance under the 2021 Plan. ​ As of June 30, 2024, there were also 1,182,952 shares of common stock reserved for issuance that were unrelated to the Company’s Equity Incentive Plans, including 1,000,000 shares reserved pursuant to unexercised warrants related to the Halston Master License (as described below) and 182,952 shares reserved pursuant to unexercised Representative’s Warrants related to the March 19, 2024 Offering (as described above). ​ ​ Warrants A summary of the Company’s warrants activity for the current six months is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​ Average Contractual ​ Aggregate ​ ​ Number of ​ Exercise Life ​ Intrinsic ​ Warrants Price (in Years) Value Outstanding and exercisable at January 1, 2024 1,116,065 ​ $ 1.67 8.46 ​ $ — Issued 182,952 ​ 0.81 ​ ​ Exercised — ​ — ​ ​ Expired/Forfeited — ​ — ​ ​ Outstanding at June 30, 2024 1,299,017 ​ $ 1.55 7.51 ​ $ — Exercisable at June 30, 2024 116,065 ​ $ 3.15 0.05 ​ $ — ​ Warrants issued during the current six months were related to the March 19, 2024 Offering (see “Public Offering and Private Placement Transactions” above for details). There was no compensation expense recognized during the current six months related to these warrants. In connection with the entrance into the Halston Master License (see Note 5), the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the current quarter and current six months was approximately $0.01 million and $0.02 million, respectively. As of June 30, 2024, no portion of this warrant had vested. Excluding the contra-revenue recognized with respect to the Halston Master License warrant, there was no compensation expense related to warrants recognized in any of the periods presented.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	9. Earnings (Loss) Per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. ​ The following table is a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share computations for the three and six months ended June 30, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ Six Months Ended ​ ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) attributable to Xcel Brands, Inc. stockholders (in thousands) ​ $ 195 ​ $ (3,468) ​ $ (6,099) ​ $ (9,111) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic weighted average number of shares outstanding ​ 23,491,238 ​ 19,735,500 ​ ​ 21,933,079 ​ 19,684,630 Add: Effect of warrants ​ 291 ​ — ​ ​ — ​ — Add: Effect of stock options ​ ​ 48,357 ​ ​ — ​ ​ — ​ ​ — Diluted weighted average number of shares outstanding ​ 23,539,886 ​ 19,735,500 ​ ​ 21,933,079 ​ 19,684,630 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic net income (loss) per share ​ $ 0.01 ​ $ (0.18) ​ $ (0.28) ​ $ (0.46) Diluted net income (loss) per share ​ $ 0.01 ​ $ (0.18) ​ $ (0.28) ​ $ (0.46) ​ As a result of the net loss for prior year quarter, current six months, and prior year six months, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share for such periods. ​ The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Stock options ​ 4,615,760 ​ 5,119,420 ​ 4,775,760 ​ 5,119,420 Warrants ​ 1,297,952 ​ 1,116,065 ​ 1,299,017 ​ 1,116,065 Total ​ 5,913,712 6,235,485 ​ 6,074,777 6,235,485 ​

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0%, resulting in an income tax provision (benefit) of $0. The effective tax rate differed from the federal statutory rate due to the recording of a valuation allowance against the provision (benefit) and any deferred tax assets or liabilities that would have otherwise been recognized, as it was considered not more likely than not that any net operating losses generated during each period will be utilized in future periods. ​ The estimated annual effective income tax rate for the current six months and the prior year six months was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods. The effective tax rate differed from the federal statutory rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	11. Related Party Transactions IM Topco, LLC As described in Note 2, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting. Service Agreement On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year. ​ For the three and six months ended June 30, 2023, the Company recognized service fee income related to this agreement of $75,000 and $150,000, respectively, which is included within net licensing revenue in the condensed consolidated statements of operations. ​ In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023. In April 2024, the services agreement was further amended to set the service fees at $150,000 per year beginning with the fiscal year ending December 31, 2024. In addition under the April 2024 amendment, IM Topco is required to prepay the service fees for the year ending December 31, 2025 at specified dates during 2024. ​ For the three and six months ended June 30, 2024, the Company recognized service fee income related to this agreement of $37,500 and $75,000, respectively, which is included within net licensing revenue in the condensed consolidated statements of operations. ​ License Agreement ​ On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year. ​ Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three and six months ended June 30, 2023, the estimated amount of such shortfall was approximately $60,000 and $120,000, respectively, which the Company recognized as royalty expense in the condensed consolidated statements of operations ​ In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 over the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities. During the current quarter and current six months, the Company paid $100,000 to IM Topco. As of June 30, 2024, the remaining payments due totaled $275,000, which is reflected within accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheets. ​ Financing Transactions ​ Public Offering and Private Placement Transactions ​ In connection with the Offering of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share which was consummated on March 19, 2024 (see Note 8 for additional details), Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares, respectively, at $0.65 per share, the same price at which the shares were sold to other purchasers in the Offering. In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Mr. D’Loren, Mr. DiSanto, and Mr. Burroughs to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering. ​

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	12. Commitments and Contingencies Contingent Obligation – Isaac Mizrahi Transaction In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand, the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was initially amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. On April 12, 2024, this agreement was further amended such that the purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025. This amendment also provided that if IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. In addition, under the amendment, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco by October 10, 2024 under the amended license agreement (see Note 11). No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation. Contingent Obligation – Lori Goldstein Earn-Out In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company had agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six As of December 31, 2022, based on the performance of the Lori Goldstein Brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023. Based on the performance of the Lori Goldstein Brand through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which would have been paid out in 2024. During the first quarter of 2024, the Company paid approximately $0.3 million of the $1.0 million earned. During the current quarter, as a result of the divestiture of the Lori Goldstein Brand (as described in Note 3), the seller waived their rights with respect to the Lori Goldstein Earn-Out amounts that had been previously earned and had not yet been paid, and terminated their rights to any future payments under the Lori Goldstein Earn-Out. As a result, the Company de-recognized approximately $1.03 million of accrued Lori Goldstein Earn-Out payments and the remaining balance of approximately $5.05 million of contingent obligations recorded on the Company’s balance sheet. As of June 30, 2024, there were no liability amounts remaining on the Company’s balance sheet related to the Lori Goldstein Earn-Out. Legal Matters From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. ​ In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

Correction of an Error

Correction of an Error	6 Months Ended
	Jun. 30, 2024
Accounting Changes and Error Corrections [Abstract]
Correction of an Error	13. Correction of an Error During the review of the Company’s condensed consolidated financial statements for the three and six months ended June 30, 2024, the Company identified an error in the calculation of previously recorded asset impairment charges. This error resulted in an understatement of the asset impairment charges reported for the three months ended March 31, 2024. Based on management’s evaluation of SEC Staff Accounting Bulletins Nos. 99 and 108 and interpretations therewith, the Company concluded that the aforementioned error was not material to the Company’s previously filed condensed consolidated financial statements for the three months ended March 31, 2024. This is further supported by the fact that this error is of a non-cash nature, does not impact the Company’s non-GAAP measures of operating performance (non-GAAP Net Income and Adjusted EBITDA), and would not likely have materially impacted a reasonable investor’s opinion of the Company’s financial condition and results of operations. ​ Because the correction of this error was not deemed to be material to the results for the three months ended March 31, 2024, and does not represent an out-of-period error for the six-month period ended June 30, 2024, the Company recorded the correction as an out-of-period adjustment in the three-month period ended June 30, 2024. Refer to the table below for details of the correction: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Condensed Consolidated Statements of Operations: For the Three Months Ended June 30, 2024 (in thousands, except per share data) ​ Before Adjustment Adjustment As Reported Asset impairment charges ​ $ 590 ​ $ 598 ​ $ 1,188 Net income (loss) attributable to Xcel Brands, Inc. stockholders ​ $ 793 ​ $ (598) ​ $ 195 Earnings (loss) per common share attributable to Xcel Brands, Inc. stockholders - basic and diluted ​ $ 0.03 ​ $ (0.02) ​ $ 0.01 ​

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Event
Subsequent Events	14. Subsequent Events On July 30, 2024, the Company entered into amendments to the employment agreements dated February 27, 2019 with each of Robert W. D’Loren, its Chairman of the Board, Chief Executive Officer and President, and Seth Burroughs, its Executive Vice President of Business Development. Pursuant to each amendment, the Company agreed with the respective executive officer that commencing July 16, 2024 and ending December 31, 2025, the executive officer shall accept and the Company shall pay for each month 40% of such executive officer’s pro rata portion of Base Salary (as defined in the respective employment agreement) for each such month through the issuance of shares of the Company’s common stock. The shares of common stock will be issued on the last day of each month, and the number of shares issuable for a month to Mr. D’Loren and Mr. Burroughs shall be determined by dividing 40% of executive officer’s pro-rated Base Salary for such month by the closing sale price of the Company’s common stock on the last trading day of such month. Each of Mr. D’Loren and Mr. Burroughs are permitted to pay the withholding tax through the exchange of a portion of the shares.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 195	$ (3,468)	$ (6,099)	$ (9,111)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Investments in Unconsolidated_2

Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables)	6 Months Ended
	Jun. 30, 2024
Acquisitions, Divestitures and Variable Interest Entities[Abstract]
Summarized financial information for IM Topco	​ Summarized financial information for IM Topco for the three and six months ended June 30, 2024 and 2023 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the six months ended ​ ​ June 30, ​ June 30, ($ in thousands) ​ 2024 ​ 2023 ​ 2024 ​ 2023 Revenues ​ $ 2,711 ​ $ 3,573 ​ $ 5,463 ​ $ 6,919 Gross profit ​ ​ 2,711 ​ ​ 3,573 ​ ​ 5,463 ​ ​ 6,919 (Loss) income from continuing operations ​ ​ (374) ​ ​ 206 ​ ​ (771) ​ ​ 113 Net (loss) income ​ ​ (374) ​ ​ 206 ​ ​ (771) ​ ​ 113

Trademarks and Other Intangib_2

Trademarks and Other Intangibles (Tables)	6 Months Ended
	Jun. 30, 2024
Trademarks and Other Intangibles [Abstract]
Schedule of trademarks and other intangibles	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Average June 30, 2024 ​ Amortization ​ Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived) 15 years ​ 58,580 ​ 22,100 ​ 36,480 Copyrights and other intellectual property 8 years ​ 429 ​ 377 ​ 52 Total ​ ​ ​ $ 59,009 ​ $ 22,477 ​ $ 36,532 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Average December 31, 2023 ​ Amortization Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived) 15 years ​ 68,880 ​ 27,431 ​ 41,449 Copyrights and other intellectual property 8 years ​ 429 ​ 358 ​ 71 Total ​ $ 69,309 ​ $ 27,789 ​ $ 41,520 ​

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Schedule of maturities of future lease obligations	​ ​ ​ ​ ​ ​ ​ Amount Year (in thousands) 2024 (July 1 through December 31) ​ $ 776 2025 ​ ​ 1,926 2026 ​ 2,060 2027 ​ 1,841 2028 ​ 570 Thereafter ​ 2,004 Total lease payments ​ ​ 9,177 Less: Discount ​ ​ 1,859 Present value of lease liabilities ​ ​ 7,318 Current portion of lease liabilities ​ ​ 1,354 Non-current portion of lease liabilities ​ $ 5,964 ​

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Schedule of debt	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ December 31, ($ in thousands) 2024 2023 Term loan debt ​ $ 4,750 ​ $ 5,000 Unamortized deferred finance costs related to term loan debt ​ (226) ​ (279) Total ​ 4,524 ​ 4,721 Current portion of debt ​ 1,000 ​ 750 Long-term debt ​ $ 3,524 ​ $ 3,971
Schedule of maturities of long-term debt	​ ​ ​ ​ ​ ​ ​ Amount of ($ in thousands) Principal Year Ending December 31, Payment 2024 (July 1 through December 31) ​ $ 500 2025 ​ 1,000 2026 ​ ​ 1,000 2027 ​ ​ 1,000 2028 ​ 1,250 Total ​ $ 4,750

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Summary of Stock Option Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​ ​ Average ​ Contractual ​ Aggregate ​ ​ Number of ​ Exercise ​ Life ​ Intrinsic ​ Options Price (in Years) Value Outstanding at January 1, 2024 5,148,540 ​ $ 2.03 4.26 ​ $ — Granted 100,000 ​ 0.85 ​ Exercised — ​ — ​ Expired/Forfeited (472,780) ​ 3.08 ​ Outstanding at June 30, 2024, and expected to vest 4,775,760 ​ $ 1.90 4.13 ​ $ — Exercisable at June 30, 2024 1,025,760 ​ $ 2.67 1.83 ​ $ —
Summary of Stock Option Activity for Non-Vested Options	​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ Average ​ ​ Number of ​ Grant Date ​ Options Fair Value Balance at January 1, 2024 3,750,000 ​ $ 0.04 Granted 100,000 ​ 0.47 Vested (100,000) ​ ​ 0.90 Forfeited or Canceled — ​ — Balance at June 30, 2024 3,750,000 ​ $ 0.03
Summary of Restricted Stock Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ Number of ​ Average ​ ​ Restricted ​ Grant Date ​ Shares Fair Value Outstanding at January 1, 2024 333,333 ​ $ 3.69 Granted 118,000 ​ 1.11 Vested (78,000) ​ 1.25 Expired/Forfeited — ​ — Outstanding at June 30, 2024 373,333 ​ $ 3.39
Summary of Warrant Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​ Average Contractual ​ Aggregate ​ ​ Number of ​ Exercise Life ​ Intrinsic ​ Warrants Price (in Years) Value Outstanding and exercisable at January 1, 2024 1,116,065 ​ $ 1.67 8.46 ​ $ — Issued 182,952 ​ 0.81 ​ ​ Exercised — ​ — ​ ​ Expired/Forfeited — ​ — ​ ​ Outstanding at June 30, 2024 1,299,017 ​ $ 1.55 7.51 ​ $ — Exercisable at June 30, 2024 116,065 ​ $ 3.15 0.05 ​ $ —

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Schedule of the basic and diluted net loss per share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ Six Months Ended ​ ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) attributable to Xcel Brands, Inc. stockholders (in thousands) ​ $ 195 ​ $ (3,468) ​ $ (6,099) ​ $ (9,111) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic weighted average number of shares outstanding ​ 23,491,238 ​ 19,735,500 ​ ​ 21,933,079 ​ 19,684,630 Add: Effect of warrants ​ 291 ​ — ​ ​ — ​ — Add: Effect of stock options ​ ​ 48,357 ​ ​ — ​ ​ — ​ ​ — Diluted weighted average number of shares outstanding ​ 23,539,886 ​ 19,735,500 ​ ​ 21,933,079 ​ 19,684,630 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic net income (loss) per share ​ $ 0.01 ​ $ (0.18) ​ $ (0.28) ​ $ (0.46) Diluted net income (loss) per share ​ $ 0.01 ​ $ (0.18) ​ $ (0.28) ​ $ (0.46)
Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Stock options ​ 4,615,760 ​ 5,119,420 ​ 4,775,760 ​ 5,119,420 Warrants ​ 1,297,952 ​ 1,116,065 ​ 1,299,017 ​ 1,116,065 Total ​ 5,913,712 6,235,485 ​ 6,074,777 6,235,485 ​

Correction of an Error (Tables)

Correction of an Error (Tables)	6 Months Ended
	Jun. 30, 2024
Accounting Changes and Error Corrections [Abstract]
Schedule of correction of errors	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Condensed Consolidated Statements of Operations: For the Three Months Ended June 30, 2024 (in thousands, except per share data) ​ Before Adjustment Adjustment As Reported Asset impairment charges ​ $ 590 ​ $ 598 ​ $ 1,188 Net income (loss) attributable to Xcel Brands, Inc. stockholders ​ $ 793 ​ $ (598) ​ $ 195 Earnings (loss) per common share attributable to Xcel Brands, Inc. stockholders - basic and diluted ​ $ 0.03 ​ $ (0.02) ​ $ 0.01 ​

Nature of Operations, Backgro_2

Nature of Operations, Background, and Basis of Presentation (Details)	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	May 31, 2022
Longaberger Licensing, LLC | Variable Interest Entity, Primary Beneficiary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	50%
IM Topco, LLC
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ownership interest	30%		30%
ORME
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ownership interest	30%	30%

Nature of Operations, Backgro_3

Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 01, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net Income (Loss)		$ 195	$ (3,468)	$ (6,099)	$ (9,111)
Non-cash expenses				7,700
Accumulated deficit		(59,948)		(59,948)		$ (53,849)
Net cash used in operating activities				(2,883)	(1,471)
Working capital, Net		1,100		1,100
Cash and cash equivalents		1,663	$ 3,507	1,663	$ 3,507	2,998	$ 4,608
Reduction in payroll costs						6,000
Reduction in operating expenses						9,000
Operating expense run rate				12,500
Term loan debt		4,750		4,750		$ 5,000
Proceeds from public offering and private placement transactions, net of transaction costs				1,902
Subsequent Event
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating expense run rate	$ 10,000
Lori Goldstein Brand | Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amount of contractual obligations relieved due to divestiture transaction		1,000		1,000
Amount of potential future contingent obligations relieved due to divestiture transaction		$ 11,300		$ 11,300

Investments in Unconsolidated_3

Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) - USD ($)			3 Months Ended		6 Months Ended
	Apr. 12, 2024	May 31, 2022	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	May 27, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on divestiture of Lori Goldstein brand			$ 3,801,000		$ 3,801,000
Loss from equity method investment					$ (1,090,000)	$ (1,030,000)
IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest		30%	30%		30%
IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from equity method investment			$ (520,000)	$ (520,000)	$ 1,030,000	$ 1,030,000
WHP | IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash flow distributable to members (in percent)	50%
Net cash flow distributable to members	$ 1,000,000
Business Venture Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash flow distributable to members (in percent)		100%
Net cash flow distributable to members		$ 1,316,200
Business Venture Agreement | WHP
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash flow distributable to members (in percent)		100%
Net cash flow distributable to members		$ 8,852,000
IM Brand trademarks and other intellectual property rights | Disposed of by Sale | IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest			70%		70%		70%

Investments in Unconsolidated_4

Investments in Unconsolidated Affiliates and Variable Interest Entities - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gross Profit	$ 2,916		$ 2,981		$ 5,100	$ 6,338
Net (loss) income	161	$ (6,345)	(3,701)	$ (5,938)	(6,184)	(9,639)
IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	2,711		3,573		5,463	6,919
Gross Profit	2,711		3,573		5,463	6,919
(Loss) income from continuing operations	(374)		206		(771)	113
Net (loss) income	$ (374)		$ 206		$ (771)	$ 113

Investments in Unconsolidated_5

Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	6 Months Ended
	Dec. 31, 2023	Jun. 30, 2024	Jun. 30, 2024
Schedule Of Asset Acquisition [Line Items]
Equity method investments	$ 17,735	$ 16,643	$ 16,643
ORME
Schedule Of Asset Acquisition [Line Items]
Members contribution	$ 150
Ownership interest	30%	30%	30%
Proportional share of the operating results		$ 40	$ 60
ORME | Other assets
Schedule Of Asset Acquisition [Line Items]
Equity method investments	$ 150	$ 90	$ 90

Investments in Unconsolidated_6

Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) - Longaberger Licensing, LLC - Variable Interest Entity, Primary Beneficiary	6 Months Ended
	Jun. 30, 2024
Schedule Of Asset Acquisition [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	50%
Hilco Global
Schedule Of Asset Acquisition [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	50%

Divestiture Transaction - Narra

Divestiture Transaction - Narrative (Details)		3 Months Ended	6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)
Gain on divestiture of Lori Goldstein brand		$ 3,801,000	$ 3,801,000
Lori Goldstein Brand
Compensation for services rendered			25,000
Total consideration			6,080,000
Waiver of earn out payments			1,030,000
Release of contingent obligations	$ 5,050,000	$ 5,050,000	5,050,000
Proceeds from sale of assets	$ 1,930,000		1,930,000
Legal fees			350,000
Gain on divestiture of Lori Goldstein brand			$ 3,800,000

Trademarks and Other Intangib_3

Trademarks and Other Intangibles - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Goodwill and Intangible Assets [Line Items]
Amortization expense for intangible assets		$ 1,520	$ 1,540	$ 3,060	$ 3,070
Unamortized net book value, intangible assets	$ 59,009	59,009		59,009		$ 69,309
Accumulated amortization	22,477	22,477		22,477		$ 27,789
Lori Goldstein Brand
Goodwill and Intangible Assets [Line Items]
Proceeds from sale of assets	1,930			1,930
Unamortized net book value, intangible assets	10,300	10,300		10,300
Accumulated amortization	$ 8,370	$ 8,370		$ 8,370

Trademarks and Other Intangib_4

Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Trademarks and Other Intangibles
Gross Carrying Amount	$ 59,009	$ 69,309
Accumulated Amortization	22,477	$ 27,789
Total	$ 36,532
Trademarks (finite-lived)
Trademarks and Other Intangibles
Weighted Average Amortization Period	15 years	15 years
Gross Carrying Amount	$ 58,580	$ 68,880
Accumulated Amortization	22,100	27,431
Total	$ 36,480	$ 41,449
Copyrights and other intellectual property
Trademarks and Other Intangibles
Weighted Average Amortization Period	8 years	8 years
Gross Carrying Amount	$ 429	$ 429
Accumulated Amortization	377	358
Total	$ 52	$ 71

Significant Contracts and Con_2

Significant Contracts and Concentrations - Qurate Agreements (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Product Information [Line Items]
Net revenue	$ 2,954	$ 6,781	$ 5,138	$ 12,831
Accounts receivable	3,055		3,055		$ 3,454
Net licensing revenue
Product Information [Line Items]
Net revenue	$ 2,826	$ 2,428	$ 5,010	$ 4,650
Sales [Member] | Customer Concentration Risk [Member] | Qurate
Product Information [Line Items]
Concentration risk, percentage	60%	24%	59%	26%
Sales [Member] | Customer Concentration Risk [Member] | Qurate | Net licensing revenue
Product Information [Line Items]
Net revenue	$ 1,770	$ 1,630	$ 3,010	$ 3,280
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Qurate
Product Information [Line Items]
Concentration risk, percentage			25%		43%
Accounts receivable	$ 770		$ 770		$ 1,500

Significant Contracts and Con_3

Significant Contracts and Concentrations - Halston Master License (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	May 15, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Subsequent Event [Line Items]
Deferred revenue, current		$ 989		$ 989		$ 889
Deferred revenue, long-term liability		3,111		3,111		3,556
Licensing revenue		$ 2,954	$ 6,781	$ 5,138	$ 12,831
Sales [Member] | Customer Concentration Risk [Member] | Halston License
Subsequent Event [Line Items]
Concentration risk, percentage		22%		25%
Net licensing revenue
Subsequent Event [Line Items]
Licensing revenue		$ 2,826	$ 2,428	$ 5,010	$ 4,650
Halston License
Subsequent Event [Line Items]
Additional royalty payable term	20 years
Total purchase price	$ 5,000
Deferred revenue		4,000		4,000		4,400
Deferred revenue, current		900		900		900
Deferred revenue, long-term liability		3,100		$ 3,100		$ 3,500
Recognition period of deferred revenue				3 years 10 months 17 days
Licensing revenue		$ 650		$ 1,290
Halston License | Minimum
Subsequent Event [Line Items]
Royalty payable term	5 years
Halston License | Maximum
Subsequent Event [Line Items]
Royalty payable term	25 years

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands			3 Months Ended			6 Months Ended
	Feb. 29, 2024	Jan. 26, 2024	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Lessee, Lease, Description [Line Items]
Sublease income			$ 200			$ 300
Lease expiration date						Oct. 30, 2027
Cash payments for operating lease expense			$ 400		$ 400	$ 800	$ 800
Weighted average remaining lease term for operating leases			4 years 11 months 19 days			4 years 11 months 19 days
Weighted average discount rate			7.71%			7.71%
Operating lease right-of-use assets			$ 4,099			$ 4,099		$ 4,453
Operating lease liability			$ 7,318			$ 7,318
Discount rate, right-of-use asset and lease liability			9.60%			9.60%
Gain on settlement of lease liability					445		445
1333 Broadway Lease
Lessee, Lease, Description [Line Items]
Annual fixed rent amount						$ 1,300
Annual fixed sublease rent amount		$ 800
Weighted average remaining lease term for operating leases			3 years 3 months 29 days			3 years 3 months 29 days
Impairment charges related to lease			$ 1,200
1333 Broadway Lease | Right-of-use assets
Lessee, Lease, Description [Line Items]
Impairment charges related to lease	$ 1,900
1333 Broadway Lease | Leasehold improvements
Lessee, Lease, Description [Line Items]
Impairment charges related to lease				$ 400
550 Seventh Avenue Lease
Lessee, Lease, Description [Line Items]
Annual fixed rent amount	$ 500
Weighted average remaining lease term for operating leases			7 years 9 months 29 days			7 years 9 months 29 days
Operating lease right-of-use assets			$ 2,600			$ 2,600
Operating lease liability			2,600			2,600
Selling, general and administrative expenses
Lessee, Lease, Description [Line Items]
Operating lease expense			$ 200		$ 400	$ 400	$ 800

Leases - Maturities of Future L

Leases - Maturities of Future Lease Obligations (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
2024 (July 1 through December 31)	$ 776
2025	1,926
2026	2,060
2027	1,841
2028	570
Thereafter	2,004
Total lease payments	9,177
Less: Discount	1,859
Present value of lease liabilities	7,318
Current portion of lease liabilities	1,354	$ 1,258
Non-current portion of lease liabilities	$ 5,964	$ 4,021

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)		3 Months Ended	6 Months Ended
	Oct. 19, 2023	Jun. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Debt
Term loan debt		$ 4,750,000	$ 4,750,000	$ 5,000,000
Unamortized deferred finance costs related to term loan debt		226,000	226,000	$ 279,000
Interest expense		$ 140,000	$ 290,000
Effective interest rate (as percentage)		11.60%	11.60%
Swap contract with IDB
Debt
Derivative, fixed interest rate	9.46%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Swap contract with IDB | IDB
Debt
Derivative, basis spread on variable rate	4.25%
New Loan Agreement
Debt
Term loan debt	$ 5,000,000	$ 4,750,000	$ 4,750,000
Unamortized deferred finance costs related to term loan debt	300,000
Quarterly installment amount	$ 250,000
New Loan Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt
Stated interest rate (as percentage)	4.25%

Debt - Net Carrying Amount of D

Debt - Net Carrying Amount of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Term loan debt	$ 4,750	$ 5,000
Unamortized deferred finance costs related to term loan debt	(226)	(279)
Total	4,524	4,721
Current portion of debt	1,000	750
Long-term debt	$ 3,524	$ 3,971

Debt - Xcel Term Loan Remaining

Debt - Xcel Term Loan Remaining Principal Payments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Oct. 19, 2023
Debt
Total	$ 4,750	$ 5,000
New Loan Agreement
Debt
2024 (July 1 through December 31)	500
2025	1,000
2026	1,000
2027	1,000
2028	1,250
Total	$ 4,750		$ 5,000

Stockholders' Equity - Public O

Stockholders' Equity - Public Offering and Private Placement Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended	6 Months Ended
	Mar. 19, 2024	Mar. 15, 2024	Mar. 14, 2024	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Purchaseable stock					23,492,117	19,795,053
Common stock issued					23,492,117	19,795,053
Proceeds from public offering and private placement transactions, net of transaction costs					$ 1,902
Warrants
Class of Stock [Line Items]
Purchaseable stock	182,952
Warrants outstanding, exercise price (in dollars per share)	$ 0.8125
Warrant term	4 years 6 months
Public Offering and Private Placement
Class of Stock [Line Items]
Common stock issued		3,579,064
Proceeds from public offering and private placement transactions, net of transaction costs		$ 1,900		$ 1,902
Public Offering
Class of Stock [Line Items]
Purchaseable stock	3,284,422	3,284,422
Common stock price	$ 0.65	$ 0.65
Net proceeds from the sale of shares	$ 1,700
Public Offering | Chief Executive Officer
Class of Stock [Line Items]
Common stock issued	146,250
Public Offering | Director
Class of Stock [Line Items]
Common stock issued	146,250
Public Offering | Executive Vice President
Class of Stock [Line Items]
Common stock issued	32,500
Private Placement
Class of Stock [Line Items]
Common stock price			$ 0.98
Net proceeds from the sale of private placement shares			$ 300
Private Placement | Agreements
Class of Stock [Line Items]
Common stock issued			294,642
Private Placement | Chief Executive Officer
Class of Stock [Line Items]
Common stock issued			132,589
Private Placement | Director
Class of Stock [Line Items]
Common stock issued			132,589
Private Placement | Executive Vice President
Class of Stock [Line Items]
Common stock issued			29,464

Stockholders' Equity - Equity I

Stockholders' Equity - Equity Incentive Plans (Details)	Jun. 30, 2024 shares
Equity Incentive Plans [Member]
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	7,837,116
2011 Equity Incentive Plan | Unexercised Stock Options
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	4,357,825
2021 Equity Incentive Plan
Stockholders' Equity
Number of common stock eligible for issuance	4,000,000
Shares are granted available for issuance (in shares)	2,945,291
Shares of common stock reserved for issuance (in shares)	2,945,291
2021 Equity Incentive Plan | Unexercised Stock Options
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	534,000
Not related to plan
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	1,182,952
Not related to plan | Warrants
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	182,952
Not related to plan | Halston License
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	1,000,000

Stockholders' Equity - Stock-ba

Stockholders' Equity - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Director and Consultants
Stockholders' Equity
Compensation expense	$ 30	$ 60	$ 170	$ 120

Stockholders' Equity - Stock Op

Stockholders' Equity - Stock Options (Details) - Employee Stock Option [Member] - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 03, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Number of Options
Outstanding, beginning balance (in shares)				5,148,540
Granted (in shares)				100,000
Exercised (in shares)				0
Expired/Forfeited (in shares)				(472,780)
Outstanding, ending balance (in shares)		4,775,760		4,775,760		5,148,540
Exercisable (in shares)		1,025,760		1,025,760
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)				$ 2.03
Granted (in dollars per share)				0.85
Exercised (in dollars per share)				0
Expired/Forfeited (in dollars per share)				3.08
Outstanding, ending balance (in dollars per share)		$ 1.90		1.90		$ 2.03
Exercisable (in dollars per share)		$ 2.67		$ 2.67
Other disclosures
Outstanding Weighted Average Remaining Contractual Life (in Years)				4 years 1 month 17 days		4 years 3 months 3 days
Exercisable Weighted Average Remaining Contractual Life (in Years)				1 year 9 months 29 days
Aggregate Intrinsic Value, Outstanding		$ 0		$ 0		$ 0
Aggregate Intrinsic Value, Exercisable		0		0
Compensation expense		20,000	$ 20,000	30,000	$ 50,000
Unrecognized compensation expense		$ 80,000		$ 80,000
Weighted average period of recognition				1 year 3 months 10 days
Non Management Directors
Number of Options
Granted (in shares)	100,000
Weighted Average Exercise Price
Granted (in dollars per share)	$ 0.85
Other disclosures
Vesting rights (percentage per year)	50%

Stockholders' Equity - Non-Vest

Stockholders' Equity - Non-Vested Options (Details) - Employee Stock Option [Member]	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Number of Options
Beginning Balance (in shares) | shares	3,750,000
Granted (in shares) | shares	100,000
Vested (in shares) | shares	(100,000)
Ending Balance (in shares) | shares	3,750,000
Weighted Average Grant Date Fair Value
Beginning Balance (in dollars per share) | $ / shares	$ 0.04
Granted (in dollars per share) | $ / shares	0.47
Vested (in dollars per share) | $ / shares	0.90
Ending Balance (in dollars per share) | $ / shares	$ 0.03

Stockholders' Equity - Stock Aw

Stockholders' Equity - Stock Awards (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended		6 Months Ended
	Apr. 03, 2024	Jan. 12, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Consultant
Number of Other than Options
Granted (in shares)		78,000
Restricted Stock
Number of Other than Options
Outstanding, beginning balance (in shares)					333,333
Granted (in shares)					118,000
Vested (in shares)					(78,000)
Expired/Forfeited (in shares)					0
Outstanding, ending balance (in shares)			373,333		373,333
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)					$ 3.69
Granted (in dollars per share)					1.11
Vested (in dollars per share)					1.25
Expired/Forfeited (in dollars per share)					0
Outstanding, ending balance (in dollars per share)			$ 3.39		$ 3.39
Other disclosures
Unrecognized compensation expense			$ 60		$ 60
Weighted average period of recognition					1 year 3 months 7 days
Common Stock
Other disclosures
Compensation expense			$ 20	$ 50	$ 130	$ 80
Common Stock | Non Management Directors
Number of Other than Options
Granted (in shares)	40,000
Common Stock | April 2025 | Non Management Directors
Other disclosures
Vesting rights (percentage per year)	50%
Common Stock | April 2026 | Non Management Directors
Other disclosures
Vesting rights (percentage per year)	50%

Stockholders' Equity - Restrict

Stockholders' Equity - Restricted Stock Units (Details) - shares	Jun. 30, 2024	Dec. 31, 2023
Stockholders' Equity
Common stock, shares outstanding (in shares)	23,492,117	19,795,053
Common stock, shares issued (in shares)	23,492,117	19,795,053
Restricted Stock
Stockholders' Equity
Common stock, shares outstanding (in shares)	0	0
Common stock, shares issued (in shares)	0	0

Stockholders' Equity - Warrants

Stockholders' Equity - Warrants (Details) - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	May 15, 2023
Other disclosures
Purchaseable stock	23,492,117			23,492,117		19,795,053
Contra-revenue related to warrants held by licensee		$ 10,000
Warrants
Number of Other than Options
Outstanding and exercisable, beginning balance (in shares)		1,116,065		1,116,065
Issued (in shares)				182,952
Exercised (in shares)				0
Expired/Forfeited (in shares)				0
Outstanding, ending balance (in shares)	1,299,017			1,299,017		1,116,065
Exercisable (in shares)	116,065			116,065
Weighted Average Exercise Price
Outstanding and exercisable, beginning balance (in dollars per share)		$ 1.67		$ 1.67
Issued (in dollars per share)				0.81
Exercised (in dollars per share)				0
Expired/Forfeited (in dollars per share)				0
Outstanding, ending balance (in dollars per share)	$ 1.55			1.55		$ 1.67
Exercisable, ending balance (in dollars per share)	$ 3.15			$ 3.15
Weighted Average Remaining Contractual Life (in Years), Outstanding				7 years 6 months 3 days		8 years 5 months 15 days
Weighted Average Contractual Life (in Years), Exercisable				18 days
Aggregate Intrinsic Value, Outstanding	$ 0			$ 0		$ 0
Aggregate Intrinsic Value, Exercisable	0			0
Other disclosures
Compensation expense	0		$ 0	0	$ 0
Warrants | Halston License
Other disclosures
Warrant term							10 years
Purchaseable stock							1,000,000
Warrants outstanding, exercise price (in dollars per share)							$ 1.50
Contra-revenue related to warrants held by licensee	$ 10,000			$ 20,000
Number of shares vested				0

Earnings (Loss) Per Share - Bas

Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share [Abstract]
Net income (loss) attributable to Xcel Brands, Inc. stockholders	$ 195	$ (3,468)	$ (6,099)	$ (9,111)
Basic weighted average common shares outstanding	23,491,238	19,735,500	21,933,079	19,684,630
Add: Effect of warrants (in shares)	291
Add: Effect of stock options (in shares)	48,357
Diluted weighted average number of shares outstanding	23,539,886	19,735,500	21,933,079	19,684,630
Basic net income (loss) per share	$ 0.01	$ (0.18)	$ (0.28)	$ (0.46)
Diluted net income (loss) per share	$ 0.01	$ (0.18)	$ (0.28)	$ (0.46)

Earnings (Loss) Per Share - Ant

Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive securities	5,913,712	6,235,485	6,074,777	6,235,485
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive securities	4,615,760	5,119,420	4,775,760	5,119,420
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive securities	1,297,952	1,116,065	1,299,017	1,116,065

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	0%	0%	0%	0%
Income tax (benefit) provision	$ 0	$ 0	$ 0	$ 0

Related Party Transactions - IM

Related Party Transactions - IM Topco, LLC & License Agreement (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	May 31, 2022
Asset Purchase Agreement
Payments for Royalties		$ 100,000		$ 100,000
Accrued Royalties		275,000		275,000
IM Topco | Services Agreement
Asset Purchase Agreement
Due from related party						$ 300,000
Revenue from services provided		$ 37,500	$ 75,000	$ 75,000	$ 150,000
IM Topco | Amended Services Agreement
Asset Purchase Agreement
Due from related party	$ 150,000
Reduction in service fees	600,000
IM Topco | License Agreement
Asset Purchase Agreement
Royalty guarantees						$ 400,000
Royalty expense			$ 60,000		$ 120,000
Additional royalty payments	$ 450,000

Related Party Transactions - Fi

Related Party Transactions - Financing Transactions (Details) - USD ($) $ / shares in Units, $ in Millions	Mar. 14, 2024	Jun. 30, 2024	Mar. 19, 2024	Mar. 15, 2024	Dec. 31, 2023
Asset Purchase Agreement
Purchaseable stock		23,492,117			19,795,053
Common stock issued		23,492,117			19,795,053
Public Offering and Private Placement
Asset Purchase Agreement
Common stock issued				3,579,064
Public Offering
Asset Purchase Agreement
Purchaseable stock			3,284,422	3,284,422
Common stock price			$ 0.65	$ 0.65
Share price			$ 0.65
Public Offering | Chief Executive Officer
Asset Purchase Agreement
Common stock issued			146,250
Public Offering | Director
Asset Purchase Agreement
Common stock issued			146,250
Public Offering | Executive Vice President [Member]
Asset Purchase Agreement
Common stock issued			32,500
Private Placement
Asset Purchase Agreement
Common stock price	$ 0.98
Net proceeds from the sale of private placement shares	$ 0.3
Private Placement | Agreements [Member]
Asset Purchase Agreement
Common stock issued	294,642
Private Placement | Chief Executive Officer
Asset Purchase Agreement
Common stock issued	132,589
Private Placement | Director
Asset Purchase Agreement
Common stock issued	132,589
Private Placement | Executive Vice President [Member]
Asset Purchase Agreement
Common stock issued	29,464

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Thousands				3 Months Ended	6 Months Ended	12 Months Ended
	Apr. 12, 2024 USD ($)	May 31, 2022 USD ($) item	Apr. 01, 2021 USD ($)	Mar. 31, 2024 USD ($)	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Amended Services Agreement | Xcel Brands | IM Topco, LLC
Commitments and Contingencies
Ownership interest	30%
Amended Services Agreement | WHP | IM Topco, LLC
Commitments and Contingencies
Ownership interest	70%
Amended Services Agreement | If Royalties Receivable Less Than Specified Amount
Commitments and Contingencies
Ownership equity transferable	12.50%
Amended Services Agreement | If Royalties Receivable Less Than Specified Amount | Xcel Brands | IM Topco, LLC
Commitments and Contingencies
Ownership interest	17.50%
Amended Services Agreement | If Royalties Receivable Less Than Specified Amount | WHP | IM Topco, LLC
Commitments and Contingencies
Ownership interest	82.50%
Amended Services Agreement | Twelve-month period ending March 31, 2025
Commitments and Contingencies
Royalty guarantees	$ 13,500
Amended Services Agreement | Year ending December 31, 2025
Commitments and Contingencies
Royalty guarantees	$ 18,000
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale
Commitments and Contingencies
Number of consecutive quarters for royalty payable term | item		4
Royalty payable term		3 years
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | Maximum
Commitments and Contingencies
Royalty guarantees		$ 13,300
Adjustments to purchase price payable		$ 16,000
Lori Goldstein Brand
Commitments and Contingencies
Contingent consideration			$ 12,500
Royalties earned					6 years
Contingent obligation (Lori Goldstein Earn-Out)			$ 6,600	$ 300		$ 200
Additional consideration is payable to the seller						$ 1,000	$ 200
Waiver of earn out payments					$ 1,030
Derecognition of contingent obligations					$ 5,050

Correction of an Error - Table

Correction of an Error - Table of Correction of Error (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Reclassification [Line Items]
Asset impairment charges	$ 1,188		$ 3,483	$ 100
Net income (loss) attributable to Xcel Brands, Inc. stockholders	$ 195	$ (3,468)	$ (6,099)	$ (9,111)
Basic earnings (loss) per share	$ 0.01	$ (0.18)	$ (0.28)	$ (0.46)
Diluted earnings (loss) per share	$ 0.01	$ (0.18)	$ (0.28)	$ (0.46)
Before Adjustment
Reclassification [Line Items]
Asset impairment charges	$ 590
Net income (loss) attributable to Xcel Brands, Inc. stockholders	$ 793
Basic earnings (loss) per share	$ 0.03
Diluted earnings (loss) per share	$ 0.03
Adjustment
Reclassification [Line Items]
Asset impairment charges	$ 598
Net income (loss) attributable to Xcel Brands, Inc. stockholders	$ (598)
Basic earnings (loss) per share	$ (0.02)
Diluted earnings (loss) per share	$ (0.02)

Subsequent Events - Narrative (

Subsequent Events - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended		6 Months Ended
	Jul. 31, 2024	Mar. 19, 2024	Mar. 15, 2024	Mar. 14, 2024	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Subsequent Event [Line Items]
Sublease income					$ 200		$ 300
Purchaseable stock					23,492,117		23,492,117	19,795,053
Common stock issued					23,492,117		23,492,117	19,795,053
Proceeds from public offering and private placement transactions, net of transaction costs							$ 1,902
Warrants
Subsequent Event [Line Items]
Purchaseable stock		182,952
Warrants outstanding, exercise price (in dollars per share)		$ 0.8125
Warrant term		4 years 6 months
Public Offering and Private Placement
Subsequent Event [Line Items]
Common stock issued			3,579,064
Proceeds from public offering and private placement transactions, net of transaction costs			$ 1,900			$ 1,902
Public Offering [Member]
Subsequent Event [Line Items]
Purchaseable stock		3,284,422	3,284,422
Common stock price		$ 0.65	$ 0.65
Net proceeds from the sale of shares		$ 1,700
Private Placement [Member]
Subsequent Event [Line Items]
Common stock price				$ 0.98
Net proceeds from the sale of private placement shares				$ 300
Agreements [Member] | Private Placement [Member]
Subsequent Event [Line Items]
Common stock issued				294,642
Chief Executive Officer | Public Offering [Member]
Subsequent Event [Line Items]
Common stock issued		146,250
Chief Executive Officer | Private Placement [Member]
Subsequent Event [Line Items]
Common stock issued				132,589
Director | Public Offering [Member]
Subsequent Event [Line Items]
Common stock issued		146,250
Director | Private Placement [Member]
Subsequent Event [Line Items]
Common stock issued				132,589
Executive Vice President [Member] | Public Offering [Member]
Subsequent Event [Line Items]
Common stock issued		32,500
Executive Vice President [Member] | Private Placement [Member]
Subsequent Event [Line Items]
Common stock issued				29,464
Subsequent Events
Subsequent Event [Line Items]
Percentage of salary paid in stock	40%
Percentage of salary divided by share price	40%